Standout Papers

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review 2023 2026 2024281
  1. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review (2023)
    Wah‐Kheong Chan, Kee Huat Chuah et al. Journal of Obesity & Metabolic Syndrome

Immediate Impact

4 standout
Sub-graph 1 of 2

Citing Papers

Associations of semaglutide with first‐time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real‐world data in the US
2024 Standout
Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease
2024 Standout
2 intermediate papers

Works of Lee-Ling Lim being referenced

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
2023 Standout

Author Peers

Author Last Decade Papers Cites
Lee-Ling Lim 231 112 11 84 6 296
Cameron Gofton 206 109 66 9 251
Shui-Xian Du 288 104 136 10 313
Luis Miguel Vazquez‐Montesino 211 117 70 7 273
Jacob George 219 102 85 14 272
Katherine Eberly 240 88 128 9 283
Francesco Gorreta 221 86 60 6 300
Anjali Deshpande 254 149 103 12 309
Ruth Sargent 261 164 114 6 301
Abbey Barnard 261 85 169 8 306
Wanqing Liu 210 100 54 5 290

All Works

Loading papers...

Rankless by CCL
2026